Book a Meeting

Anti-CD40 Antibody, Non-Fucosylated (BioBet-146ZP)

Cat#: BioBet-146ZP
Target: CD40
Isotype: IgG1
Host: Humanized
Species Reactivity: Human

Description Anti-CD40 Antibody, Non-Fucosylated (BioBet-146ZP) is a humanized monoclonal IgG1 antibody against CD40. This product is an ADCC enhanced antibody produced by our Afuco™ platform.

Antibody Indication Lymphoma, B cell

Classification Therapeutic antibody; biobetter

Cooperation Seeking Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CD40 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.

Official Name CD40

Full Name CD40 Molecule

Background CD40 (CD40 Molecule) is a Protein Coding gene.
Diseases associated with CD40 include Immunodeficiency With Hyper-Igm, Type 3 and Cd40 Ligand Deficiency.
Among its related pathways are NLR Proteins and Cytokine Signaling in Immune system.
Gene Ontology (GO) annotations related to this gene include enzyme binding and receptor activity.
An important paralog of this gene is TNFRSF11A.

Alternative Names Tumor necrosis factor receptor superfamily member 5; TNFRSF5; p50

Gene ID 958

UniProt ID P25942

Cellular Localization Plasma membrane, Extracellular region or secreted

Involvement in Disease Diseases associated with CD40 include Immunodeficiency With Hyper-Igm, Type 3 and Immunodeficiency With Hyper-Igm, Type 1.

Related Pathways Its related pathways are Transcriptional misregulation in cancer and NF-KappaB Family Pathway.

Function TNFSF5/CD40LG receptor (PubMed: 31331973). ERK is activated by TRAF6- and map3k8-mediated signals in macrophages and B cells, leading to the induction of immunoglobulin secretion (by similarity).

Field of research Cell Biology and Cellular Response antibody; Developmental Biology antibody; Immune System antibody; Pro-B Cell Marker antibody; Pre-B Cell Marker antibody

Post-translational modifications 1.Glycosylation at Asn153 and Asn180 2.Glycosylation at Asn153 and Asn180 3.Glycosylation at Asn153 and Asn180

Biologic Classification Protein Based Therapies
Monoclonal antibody (mAb)

Antibody Isotype IgG1

Antibody Clone BioBet-146ZP

Description This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD40. Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.

Antibody Indication Lymphoma, B cell

Lymphoma, B cell

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *

ISO 9001 Certified - Creative Biolabs Quality Management System.
© 2026 Creative Biolabs. All rights reserved.
Merry Christmas Merry Christmas